Differential effects of nicotinic acid in subjects with different LDL subclass patterns

Atherosclerosis

Volumn 95, Issue 1, 1992, Pages 69-76

  Superko, H Robert ^a   Krauss, Ronald M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholesterol; LDL subclass; Nicotinic acid; Triglycerides

Indexed keywords

LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

CHOLESTEROL; CORONARY DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL; LIPOPROTEINS, LDL CHOLESTEROL; MALE; MIDDLE AGE; NIACIN; RISK FACTORS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TRIGLYCERIDES;

EID: 0026724433     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(92)90177-I     Document Type: Article

References (23)

1. Low density lipoprotein subclass patterns and risk of myocardial infarction
2. Linkage of atherogenic lipoprotein phenotype to the low-density lipoprotein receptor locus on the short arm of chromosome 19
3. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia
4. Hyperapo B: a pleiotropic phenotype characterized by dense low-density lipoprotein and associated with coronary artery disease
5. Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition
6. Changes in lipoprotein subfractions during dietinduced and exercise-induced weight loss in moderately overweight men
7. Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses and postprandial lipemia
8. Low density lipoprotein particle size and coronary artery disease
9. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men
10. Natural history of myocardial infarction in the coronary drug project: Long-term prognostic importance of serum lipid levels
11. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts
12. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
13. Regression of coronary atherosclerosis during treatment of familial hyper cholesterolemia with combined drug regimens
14. Beneficial angiographic and clinical response to multifactor modification in the Stanford Coronary Risk Intervention Project (SCRIP)
15. The Centers for Disease Control/National Heart Lung and Blood Institute Lipid Standardization Program — 30 years of collaboration
16. Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol
17. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
18. Nondenaturing polyacrylamide gradient gel electrophoresis
19. Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects
20. Genetic control of lowdensity-lipoprotein subclasses
21. Inheritance of low density lipoprotein subclass patterns: Results of complex segregation analysis
22. Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacin
23. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk